United Kingdom Survey Finds AstraZeneca AstraVaccine COVID-19

0
4

EU-AstraZeneca-700x420.jpg

LONDON – LONDON The British enthusiasm for the AstraZeneca vaccine COVID-19 has diminished in recent months, indicating growing uneasiness about the potential linkages between AstraZeneca and the unusual negative adverse events.

According to the nearly 5,000-person survey, the proportion of people who said they wanted COVID-19 vaccination as soon as possible had increased significantly.However, close to a quarter of the people surveyed believed that AstraZeneca causes blood clots, up from 13% last month.

The AstraZeneca shot, which has been established by Oxford University scientists and has proven 76 per cent successful in prevention of symptomatic COVID-19, has dental confidence reports of potential ties to very rare blood clots.

After reports of blood clots in combination with low platelets in a limited number of people who got them, over a dozen European countries suspended temporarily their use. Many countries have resumed shooting, but there are some restrictions.

According to Bobby Duffy, Director of King’s College London’s Policy Institute, “the fear of the blood cloth has influenced the way some [UK] public opinion views the AstraZeneca vaccine—but has not diminished trust in all vaccines.”

“Indeed, the trend towards greater vaccination commitment—and rapidly—with the rollout going so well and without the evidence of extreme, wide-ranging issues.”

The safety of the vaccine has been tested, in line with reports of blood clots, both by the European Medicines Agency (EMA) and the UK Medicines & Health Care Regulatory Agency (MHRA). They claim that no causal association has occurred and that the benefits of COVID-19 prevention far outweigh any harm.

Between April 1 and April 16, the UK survey covered 4,896 UK adults between 18 and 75 years of age. It was planned to monitor why the view of COVID-19 vaccines changed. This was a follow-up to a study that was first carried out at the end of last year.

It has found 17% of respondents now claim they would prefer the AstraZeneca vaccine if they had a preference — down from 24% by the end of March.

It also found that the majority of people questioned whether the shot triggers blood clots will most likely say it’s wrong or not.

LEAVE A REPLY

Please enter your comment!
Please enter your name here